Systemic corticosteroids in COPD: An unresolved clinical dilemma

Chest

Volumn 110, Issue 4, 1996, Pages 867-869

  Niewoehner, D E ^a   Erbland, M L ^a  

^a Bldg 70   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; METHYLPREDNISOLONE; THEOPHYLLINE;

CATARACT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; EDITORIAL; EMERGENCY WARD; FORCED EXPIRATORY VOLUME; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MYOPATHY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SPIROMETRY; TREATMENT OUTCOME;

EID: 0029995676     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.4.867-a     Document Type: Editorial

References (8)

1. Stoller JK Gerbarg ZB Feinstein AR. Corticosteroids in stable chronic obstructive pulmonary disease: reappraisal of efficacy J Gen Intern Med 2 1987 29 35
2. Callahan CM Dittus RS Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis Ann Intern Med 114 1991 216 223
3. Albert RK Martin TR Lewis SW. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency Ann Intern Med 92 1980 753 758
4. Emerman CL Connors AF Lukens TW A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD Chest 95 1989 563 567
5. Rostom A Mink S Hébert PC The long term efficacy of methylprednisolone in the treatment of acute exacerbation of COPD [abstract] Chest 106 suppl 1994 161
6. Glenny RW. Steroids in COPD The scripture according to Albert [letter] Chest 91 1987 289 290
7. Mendella LA Manfreda J Warren CPW Steroid response in stable chronic obstructive pulmonary disease Ann Intern Med 96 1982 17 21
8. Blackwelder WC. “Proving the null hypothesis” in clinical trials Control Clin Trials 3 1982 345 353